Скачать или смотреть Development of a T cell engineering platform for fully individualized neoantigen specific TCR...

Presented By: Xiangjun Kong, Ph.D.

Speaker Biography: Dr. Xiangjun Kong is a Principal Scientist at Neogene Therapeutics. He has extensive research experience in high-throughput functional screening and genome editing technologies. Before joining Neogene, he was a postdoc fellow at the Netherlands Cancer Institute in the laboratory of Professor Daniel Peeper, where he co-developed and published several novel targeted and immune therapy strategies for cancer. He received his Ph.D. in Cell Biology in the laboratory of Professor Tao Zhu from the University of Science and Technology of China.


Webinar: Development of a T cell engineering platform for fully individualized neoantigen specific TCR...

Webinar Abstract: Adoptive transfer of T cell receptor (TCR)-edited T cells to target cancer neoantigens is a promising new immunotherapy approach. We have developed a platform that can identify neoantigen-reactive TCRs in a high-throughput and patient-specific manner...

Labroots on Social:
Facebook:   / labrootsinc  
Twitter:   / labroots  
LinkedIn:   / labroots  
Instagram:   / labrootsinc  
Pinterest:   / labroots  
SnapChat: labroots_inc